Northern Trust Corp Surface Oncology, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.61 - $1.03 $16,420 - $27,726	26,919 Added 44.94%	86,824 $60,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $4,987 - $9,975	4,750 Added 8.61%	59,905 $62,000
Q2 2022 Aug 12, 2022	SELL	$1.42 - $3.15 $343,560 - $762,123	-241,944 Reduced 81.44%	55,155 $90,000
Q1 2022 May 13, 2022	SELL	$2.65 - $5.08 $37,206 - $71,323	-14,040 Reduced 4.51%	297,099 $873,000
Q4 2021 Feb 08, 2022	BUY	$4.73 - $7.9 $86,890 - $145,123	18,370 Added 6.27%	311,139 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $31,310 - $48,422	6,068 Added 2.12%	292,769 $2.22 Million
Q2 2021 Aug 13, 2021	BUY	$6.45 - $9.09 $1.6 Million - $2.25 Million	247,492 Added 631.21%	286,701 $2.14 Million
Q1 2021 May 12, 2021	BUY	$7.25 - $13.82 $8,069 - $15,381	1,113 Added 2.92%	39,209 $306,000
Q4 2020 Feb 11, 2021	SELL	$6.87 - $10.48 $5,544 - $8,457	-807 Reduced 2.07%	38,096 $352,000
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $108,946 - $155,669	21,531 Added 123.94%	38,903 $268,000
Q1 2020 May 14, 2020	BUY	$1.44 - $3.95 $3,977 - $10,909	2,762 Added 18.9%	17,372 $32,000
Q3 2019 Nov 13, 2019	SELL	$1.4 - $2.84 $134,227 - $272,290	-95,877 Reduced 86.78%	14,610 $21,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $4.89 $20,344 - $36,176	-7,398 Reduced 6.28%	110,487 $311,000
Q1 2019 May 13, 2019	SELL	$4.11 - $5.88 $6,378 - $9,125	-1,552 Reduced 1.3%	117,885 $562,000
Q4 2018 Feb 12, 2019	BUY	$3.65 - $10.69 $145,868 - $427,215	39,964 Added 50.29%	119,437 $506,000
Q3 2018 Nov 14, 2018	BUY	$8.92 - $17.83 $1,409 - $2,817	158 Added 0.2%	79,473 $869,000
Q2 2018 Aug 14, 2018	BUY	$12.83 - $17.41 $1.02 Million - $1.38 Million	79,315 New	79,315 $1.29 Million

Others Institutions Holding SURF

# of Institutions

Shares Held

315K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

171K
Shares

$0
0.24% of portfolio
Kingsbury Capital Investment Advisors LLC Evanston, IL

144K
Shares

$0
0.23% of portfolio

View Full List

About Surface Oncology, Inc.

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

More about SURF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account